BNTC - Benitec Biopharma Limited

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in AUD. All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue4,62011,0934,0543,399
Cost of Revenue45127213940
Gross Profit4,16910,8213,9153,359
Operating Expenses
Research Development6,8906,92513,2876,228
Selling General and Administrative8,7269,09611,7108,142
Non Recurring----
Others----
Total Operating Expenses16,26116,51025,42714,410
Operating Income or Loss-11,641-5,417-21,373-11,011
Income from Continuing Operations
Total Other Income/Expenses Net1-273-3,405-498
Earnings Before Interest and Taxes-11,641-5,417-21,373-11,011
Interest Expense----
Income Before Tax-11,640-5,690-24,778-11,509
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-11,640-5,690-24,778-11,509
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-11,640-5,690-24,778-11,509
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-11,640-5,690-24,778-11,509